Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.07
Price to sales ratio
61.18

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4821
ALZN
Alzamend Neuro, Inc. - Common Stock
1.66 USD-0.60%+9.93%+28.68%-32.52%7.95 M USD
4823
AIM
AIM ImmunoTech Inc. Common Stock
0.26 USD+4.00%0.00%-3.70%-89.65%7.91 M USD
4829
ENSC
Ensysce Biosciences, Inc. - Common Stock
0.40 USD0.00%+8.11%+60.00%+4.58%7.78 M USD
4833
ACXP
Acurx Pharmaceuticals, Inc. - Common Stock
1.44 USD-1.37%-2.04%-0.69%-25.00%7.59 M USD

Frequently asked questions about Skye Bioscience, Inc. Common Stock

What is the Skye Bioscience, Inc. Common Stock stock price today?

The current price of Skye Bioscience, Inc. Common Stock (SKYE) is 1.78. Over the past 24 hours, the stock has changed by -8.72%. Follow the SKYE chart for real-time price dynamics.

What is the stock ticker of Skye Bioscience, Inc. Common Stock?

Skye Bioscience, Inc. Common Stock trades under the ticker SKYE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Skye Bioscience, Inc. Common Stock stock going up?

SKYE has changed by -21.24% over the last week, +212.28% over the last month, and +122.50% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Skye Bioscience, Inc. Common Stock?

Skye Bioscience, Inc. Common Stock currently has a market capitalization of 7.88 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Skye Bioscience, Inc. Common Stock earnings last quarter?

Last quarter, Skye Bioscience, Inc. Common Stock reported earnings of -2.16 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Skye Bioscience, Inc. Common Stock revenue for the last quarter?

Skye Bioscience, Inc. Common Stock reported quarterly revenue of 178.2 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Skye Bioscience, Inc. Common Stock net income for the last quarter?

Skye Bioscience, Inc. Common Stock reported net income of -10.79 M for the last quarter. The previous quarter showed -12.51 M, which means net income changed by +13.77%.

How many employees does Skye Bioscience, Inc. Common Stock have?

As of the latest available data, Skye Bioscience, Inc. Common Stock has 12 employees. Workforce size can provide additional context about the company's scale and operations.

What is Skye Bioscience, Inc. Common Stock EBITDA?

Skye Bioscience, Inc. Common Stock EBITDA is -10.73 M, and its EBITDA margin is -6 018.8%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Skye Bioscience, Inc. Common Stock stock?

You can buy Skye Bioscience, Inc. Common Stock (SKYE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Skye Bioscience, Inc. Common Stock stock?

Investing in Skye Bioscience, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SKYE chart and related analysis on metatrader.com as part of your research.

News